Literature DB >> 22964929

Comparison of two experimental models of pulmonary hypertension.

Igor Bastos Polonio1, Milena Marques Pagliarelli Acencio, Rogério Pazetti, Francine Maria de Almeida, Mauro Canzian, Bárbara Soares da Silva, Karina Aparecida Bonifácio Pereira, Rogério de Souza.   

Abstract

OBJECTIVE: To compare two models of pulmonary hypertension (monocrotaline and monocrotaline+pneumonectomy) regarding hemodynamic severity, structure of pulmonary arteries, inflammatory markers (IL-1 and PDGF), and 45-day survival.
METHODS: We used 80 Sprague-Dawley rats in two study protocols: structural analysis; and survival analysis. The rats were divided into four groups: control; monocrotaline (M), pneumonectomy (P), and monocrotaline+pneumonectomy (M+P). In the structural analysis protocol, 40 rats (10/group) were catheterized for the determination of hemodynamic variables, followed by euthanasia for the removal of heart and lung tissue. The right ventricle (RV) was dissected from the interventricular septum (IS), and the ratio between RV weight and the weight of the left ventricle (LV) plus IS (RV/LV+IS) was taken as the index of RV hypertrophy. In lung tissues, we performed histological analyses, as well as using ELISA to determine IL-1 and PDGF levels. In the survival protocol, 40 animals (10/group) were followed for 45 days.
RESULTS: The M and M+P rats developed pulmonary hypertension, whereas the control and P rats did not. The RV/LV+IS ratio was significantly higher in M+P rats than in M rats, as well as being significantly higher in M and M+P rats than in control and P rats. There were no significant differences between the M and M+P rats regarding the area of the medial layer of the pulmonary arteries; IL-1 and PDGF levels; or survival.
CONCLUSIONS: On the basis of our results, we cannot conclude that the monocrotaline+pneumonectomy model is superior to the monocrotaline model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964929     DOI: 10.1590/s1806-37132012000400007

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  5 in total

1.  Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats.

Authors:  Igor Bastos Polonio; Milena Marques Pagliareli Acencio; Rogério Pazetti; Francine Maria de Almeida; Bárbara Soares da Silva; Karina Aparecida Bonifácio Pereira; Rogério Souza
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

2.  Left ventricular dysfunction in patients with suspected pulmonary arterial hypertension.

Authors:  Francisca Gavilanes; José Leonidas Alves; Caio Fernandes; Luis Felipe Lopes Prada; Carlos Viana Poyares Jardim; Luciana Tamie Kato Morinaga; Bruno Arantes Dias; Susana Hoette; Rogerio Souza
Journal:  J Bras Pneumol       Date:  2014 Nov-Dec       Impact factor: 2.624

3.  Compensatory lung growth after bilobectomy in emphysematous rats.

Authors:  Francine Maria Almeida; Beatriz Mangueira Saraiva-Romanholo; Rodolfo Paula Vieira; Henrique Takachi Moriya; Ana Paula Ligeiro-de-Oliveira; Fernanda Dtqs Lopes; Hugo C Castro-Faria-Neto; Thais Mauad; Milton Arruda Martins; Rogerio Pazetti
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

4.  Publications in the Brazilian Journal of Pulmonology.

Authors:  Carlos Roberto Ribeiro Carvalho
Journal:  J Bras Pneumol       Date:  2013 Jan-Feb       Impact factor: 2.624

5.  Plexiform Lesions in an Experimental Model of Monocrotalin-Induced Pulmonary Arterial Hypertension.

Authors:  Douglas Mesadri Gewehr; Gabriela Rodrigues Salgueiro; Lucia de Noronha; Fernando Bermudez Kubrusly; Luiz Fernando Kubrusly; Gabriel Antonio Coltro; Paola Cardoso Preto; Andressa de Souza Bertoldi; Heloisa Iacomo Vieira
Journal:  Arq Bras Cardiol       Date:  2020-09       Impact factor: 2.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.